Showing results (961-970 of 1,984) with videos related to
Sort By:
Pageof 199
The Lancet. Neurology|March 2, 2015
Alteplase versus tenecteplase for thrombolysis after ischaemic stroke (ATTEST): a phase 2, randomised, open-label, blinded endpoint studyXuya Huang, Bharath Kumar Cheripelli, Suzanne M Lloyd, et al.The Lancet. Neurology|September 8, 2012
MRI profile and response to endovascular reperfusion after stroke (DEFUSE 2): a prospective cohort studyMaarten G Lansberg, Matus Straka, Stephanie Kemp, et al.The Lancet. Neurology|February 10, 2015
CHCHD2 mutations in autosomal dominant late-onset Parkinson's disease: a genome-wide linkage and sequencing studyManabu Funayama, Kenji Ohe, Taku Amo, et al.The Lancet. Neurology|April 7, 2015
Sensitivity and specificity of threshold tracking transcranial magnetic stimulation for diagnosis of amyotrophic lateral sclerosis: a prospective studyParvathi Menon, Nimeshan Geevasinga, Con Yiannikas, et al.The Lancet. Neurology|March 17, 2015
Pathological mechanisms in progressive multiple sclerosisDon H Mahad, Bruce D Trapp, Hans LassmannThe Lancet. Neurology|March 17, 2015
Treatment of progressive multiple sclerosis: what works, what does not, and what is neededAnthony Feinstein, Jenny Freeman, Albert C LoThe Lancet. Neurology|May 20, 2023
Diagnostic criteria for autoimmune encephalitis: utility and pitfalls for antibody-negative diseaseJosep Dalmau, Francesc GrausThe Lancet. Neurology|March 17, 2023
Admission systolic blood pressure and effect of endovascular treatment in patients with ischaemic stroke: an individual patient data meta-analysisNoor Samuels, Rob A van de Graaf, Maxim J H L Mulder, et al.The Lancet. Neurology|August 2, 2016
Atypical inflammatory demyelinating syndromes of the CNSTodd A Hardy, Stephen W Reddel, Michael H Barnett, et al.The Lancet. Neurology|June 28, 2015
Pioglitazone in early Parkinson's disease: a phase 2, multicentre, double-blind, randomised trialPageof 199